What are the applicable genetic test recommendations for me

According to the NCCN Guidelines for Prostate Cancer (2023), genetic testing is recommended in several specific situations:

1. For metastatic prostate cancer (Stage IV):

• The NCCN strongly recommends germline genetic testing for all men with metastatic prostate cancer, regardless of family history
• Testing should include genes such as BRCA1, BRCA2, ATM, PALB2, and other DNA repair genes
• This testing is important because it can impact treatment decisions, particularly regarding the use of PARP inhibitors

The American Society of Clinical Oncology (ASCO) guidelines also recommend genetic testing for:

• Men with metastatic prostate cancer
• Those with family history of certain cancers
• Individuals with high-risk prostate cancer features

The National Cancer Institute (NCI) highlights that genetic test results can:

• Help determine if certain targeted therapies might be effective
• Identify if family members might benefit from genetic counseling
• Guide clinical trial eligibility

Important recommendations:

1. Discuss genetic testing with your oncologist
2. Consider meeting with a genetic counselor before testing
3. Testing should be done at a certified laboratory
4. Results should be interpreted by qualified healthcare professionals

Remember: These are general guidelines, and your healthcare team will determine the most appropriate testing strategy based on your specific situation.